10
SHIRI ET AL.
pure polyhydroquinoline derivatives were obtained in excel-
lent yields (91–99%).
N‐H). 13C NMR (DMSO, 100 MHz, δ, ppm): 67.1, 114.9,
115.4, 117.6, 127.4, 127.9, 128.8, 129, 133.8, 142.1, 148.4,
164.1.
2‐(3‐Nitrophenyl)‐2,3‐dihydroquinazolin‐4(1H)‐one (2 l).
1H NMR (400 MHz, DMSO‐d6, δ, ppm): 5.98 (s, 1H), 6.72
(t, J = 8 Hz, 1H, Ar‐H), 6.82 (d, J = 8 Hz, 1H, Ar‐H), 7.29
(td, J = 6.8, 1.6 Hz, 1H, Ar‐H), 7.38 (brs, 1H, N‐H), 7.65
(dd, J = 8, 1.6 Hz, 1H, Ar‐H), 7.71 (t, J = 8 Hz, 1H, Ar‐
H), 7.97 (d, J = 7.6 Hz, 1H, Ar‐H), 8.23 (dq, J = 8,
1.6 Hz, 1H, Ar‐H), 8.39 (t, J = 2 Hz, 1H, Ar‐H), 8.57 (brs,
1H, N‐H). 13C NMR (DMSO, 100 MHz, δ, ppm): 65.7,
115.1, 115.4, 118, 122.1, 123.8, 127.9, 130.5, 133.8, 134.1,
144.7, 147.8, 148.2, 163.9.
Ethyl‐4‐(4‐methoxyphenyl)‐2,7,7‐trimethyl‐5‐oxo‐1,4,5,
6,7,8‐hexahydroquinolin‐3‐carboxylate (4b). 1H NMR
(400 MHz, DMSO‐d6, δ, ppm): 0.87 (s, 3H), 1.02 (s, 3H),
1.15 (t, J = 6.8 Hz, 3H), 1.99 (d, J = 16.4 Hz, 1H), 2.18
(d, J = 16 Hz, 1H), 2.28–2.32 (m, 4H), 2.43 (d,
J = 16.8 Hz, 1H), 3.68 (s, 3H), 3.99 (q, J = 6.8 Hz, 2H),
4.82 (s, 1H), 6.76 (d, J = 8.4 Hz, 2H, Ar‐H), 7.08 (d,
J = 8.8 Hz, 2H, Ar‐H), 9.03 (brs, 1H, N‐H). 13C NMR
(DMSO, 100 MHz, δ, ppm): 14.6, 18.8, 27, 29.6, 32.6,
35.4, 50.8, 55.3, 59.5, 104.4, 110.7, 113.5, 128.9, 140.5,
145.1, 149.7, 157.8, 167.4, 194.7.
Ethyl‐4‐(4‐fluorophenyl)‐2,7,7‐trimethyl‐5‐oxo‐1,4,5,6,7,
8‐hexahydroquinolin‐3‐carboxylate (4d). 1H NMR (400 MHz,
DMSO‐d6, δ, ppm): 0.85 (s, 3H), 1.02 (s, 3H), 1.13 (t,
J = 7.2 Hz, 3H), 1.99 (d, J = 16 Hz, 1H), 2.18 (d,
J = 16 Hz, 1H), 2.28–2.32 (m, 4H), 2.43 (d, J = 16.8 Hz,
1H), 3.98 (q, J = 7.2 Hz, 2H), 4.87 (s, 1H), 6.99–7.20 (m,
4H, Ar‐H), 9.11 (brs, 1H, N‐H). 13C NMR (DMSO,
100 MHz, δ, ppm): 14.6, 18.8, 26.7, 29.6, 32.6, 35.8, 50.7,
59.5, 103.9, 110.4, 114.7, 129.6, 144.3, 145.7, 149.95,
159.7, 167.2, 194.7.
Ethyl‐4‐(4‐bromophenyl)‐2,7,7‐trimethyl‐5‐oxo‐1,4,5,6,
7,8‐hexahydroquinolin‐3‐carboxylate (4f). 1H NMR
(400 MHz, DMSO‐d6, δ, ppm): 0.85 (s, 3H), 1.02 (s, 3H),
1.13 (t, J = 7.2 Hz, 3H), 1.99 (d, J = 16 Hz, 1H), 2.18 (d,
J = 16 Hz, 1H), 2.27–2.31 (m, 4H), 2.43 (d, J = 17.2 Hz,
1H), 3.98 (q, J = 7.2 Hz, 2H), 4.85 (s, 1H), 7.11–7.14 (m,
2H, Ar‐H), 7.38, 7.41 (m, 2H, Ar‐H), 9.13 (brs, 1H, N‐H).
13C NMR (DMSO, 100 MHz, δ, ppm): 14.6, 18.8, 26.9,
29.6, 32.6, 36.2, 50.6, 59.6, 103.5, 110.1, 119.19, 130.2,
131.1, 145.9, 147.5, 150.1, 167.1, 194.7.
4.8 | General procedure for Br3‐TBA‐Fe3O4‐catalysed
Knoevenagel condensation
A mixture of aldehyde (1 mmol), activated methylene com-
pounds (1.05 mmol) and Br3‐TBA‐Fe3O4 (10 mg) in water
(2 ml) was stirred at 70°C. Reaction progress was monitored
by TLC (acetone–n‐hexane, 3:7). After the time specified in
Tables 6 and 7, the reaction mass was allowed to cool to room
temperature. Ethyl acetate (3 × 5 ml) was added to the reac-
tion mixture and the catalyst was separated using an external
magnet. Ethyl acetate was evaporated under reduced pressure
to afford the crude products. The obtained crude products
were further recrystallized from ethanol to afford the pure
final products (85–98%).
4.9 | Spectroscopic data
All the products reported here are known compounds and the
spectroscopic data matched with literature values. Data for
some of the compounds are given below.
2‐(4‐Chlorophenyl)‐2,3‐dihydroquinazolin‐4(1H)‐one (2a).
1H NMR (400 MHz, DMSO‐d6, δ, ppm): 5.79 (s, 1H), 6.70
(t, J = 7.6 Hz, 1H, Ar‐H), 6.76 (d, J = 8 Hz, 1H, Ar‐H),
7.16 (brs, 1H, N‐H), 7.24–7.29 (td, J = 7.6, 1.6 Hz, 1H,
Ar‐H), 7.46–7.49 (dt, J = 8.8, 2 Hz, 2H, Ar‐H), 7.51–7.53
(dt, J = 8.4, 2 Hz, 2H, Ar‐H), 7.62 (dd, J = 7.6, 1.6 Hz,
1H, Ar‐H), 8.35 (brs, 1H, N‐H). 13C NMR (DMSO,
100 MHz, δ, ppm): 66.3, 114.9, 115.4, 117.8, 127.9, 128.8,
129.2, 133.5, 133.9, 141.1, 148.1, 164.
2‐(4‐Methylphenyl)‐2,3‐dihydroquinazolin‐4(1H)‐one (2c).
1H NMR (400 MHz, DMSO‐d6, δ, ppm): 2.31 (s, 3H, CH3),
5.73 (s, 1H), 6.68 (t, J = 7.6 Hz, 1H, Ar‐H), 6.75 (d,
J = 8.4 Hz, 1H, Ar‐H), 7.07 (brs, 1H, N‐H), 7.20–7.27 (m,
3H, Ar‐H), 7.39 (d, J = 8 Hz, 2H, Ar‐H), 7.62 (dd, J = 7.6,
1.2 Hz, 1H, Ar‐H), 8.25 (brs, 1H, N‐H). 13C NMR (DMSO,
100 MHz, δ, ppm): 21.2, 66.9, 114.9, 115.5, 117.5, 127.3,
127.8, 129.3, 133.7, 138.2, 139.1, 148.4, 164.1.
2‐(4‐Nitrophenyl)‐2,3‐dihydroquinazolin‐4(1H)‐one (2e).
1H NMR (400 MHz, DMSO‐d6, δ, ppm): 5.94 (t, J = 2 Hz,
1H, CH), 6.71 (t, J = 7.6 Hz, 1H, Ar‐H), 6.79 (d, J = 7.6 Hz,
1H, Ar‐H), 7.26–7.30 (td, J = 7.6, 1.6 Hz, 1H, Ar‐H), 7.35
(brs, 1H, N‐H), 7.62–7.65 (dd, J = 8, 1.6 Hz, 1H, Ar‐H),
7.75–7.79 (dt, J = 8.8, 2 Hz, 2H, Ar‐H), 8.26–8.30 (dt,
J = 9.2, 2 Hz, 2H, Ar‐H), 8.55 (brs, 1H, N‐H). 13C NMR
(DMSO, 100 MHz, δ, ppm): 66.8, 115, 115.4, 118, 124.1,
127.9, 128.5, 134.1, 147.7, 147.9, 149.8, 163.8.
Ethyl‐2,7,7‐trimethyl‐5‐oxo‐1,4,5,6,7,8‐hexahydroquino-
1
lin‐3‐carboxylate (4j). H NMR (400 MHz, DMSO‐d6, δ,
ppm): 0.86 (s, 3H), 1.02 (s, 3H), 1.14 (t, J = 7.2 Hz, 3H),
1.99 (d, J = 16 Hz, 1H), 2.18 (d, J = 16 Hz, 1H),
2.29–2.33 (m, 4H), 2.44 (d, J = 17.2 Hz, 1H), 3.99 (q,
J = 7.2 Hz, 2H), 4.88 (s, 1H), 7.06–7.21 (m, 5H, Ar‐H),
9.07 (brs, 1H, N‐H). 13C NMR (DMSO, 100 MHz, δ,
ppm): 14.6, 18.8, 26.9, 29.6, 32.6, 36.4, 50.7, 59.5, 104.1,
110.5, 126.1, 127.9, 128.145.5, 148.1, 150, 167.3, 194.7.
Ethyl‐4‐(3‐bromophenyl)‐2,7,7‐trimethyl‐5‐oxo‐1,4,5,6,7,
8‐hexahydroquinolin‐3‐carboxylate (4 l). 1H NMR (400 MHz,
2‐Phenyl‐2,3‐dihydroquinazolin‐4(1H)‐one (2j). 1H
NMR (400 MHz, DMSO‐d6, δ, ppm): 5.77 (s, 1H), 6.69 (t,
J = 8 Hz, 1H, Ar‐H), 6.77 (d, J = 7.6 Hz, 1H, Ar‐H), 7.13
(brs, 1H, N‐H), 7.26 (td, J = 8, 1.6 Hz, 1H, Ar‐H),
7.34–7.43 (m, 3H, Ar‐H), 7.51 (dd, J = 6.8, 1.2 Hz, 2H,
Ar‐H), 7.63 (dd, J = 7.6, 1.2 Hz, 1H, Ar‐H), 8.31 (brs, 1H,